Amarin Corp Plc (AMRN)

[HDGabor]

I agree: "Do not expect the FDA to change their position on the study being powered 90%"

Data collection will be in 01/2016-07/2016 (15-50%) and IF they will release the number of event in placebo and Vascepa group we could calculate the exact efficiency, BUT the final result (after analysis) will be released during 07-12/2016 (I guess the analysis will take 6 months at least). As Biwatch wrote on seekingalpha, if V is at least 25% effective (Power: 99%) R-IT will be stoped.

Regarding financial: Currently I expect the break even in Q22015, however too many unknown conditions are exist (script trend is temporary or constant, KOWA effect, OPEX decrease rate, etc.). I will update my model after any new relevant info and I guess we will have more exact picture after the Q2 10-Q (and after the OND's decision)